Breaking News Instant updates and real-time market news.

CDXC

ChromaDex

$4.37

0.19 (4.55%)

06:43
08/07/18
08/07
06:43
08/07/18
06:43

ChromaDex, Watsons expand TRU NIAGEN retail partnership through 2021

ChromaDex announced the expansion of its partnership with A.S. Watson Group until September 2021, as well as plans to launch TRU NIAGEN in Watsons Turkey in late 2018. As part of the expanded agreement, Watsons is committed to growing the TRU NIAGEN market in Hong Kong and Macau through mid-September 2021.

  • 09

    Aug

CDXC ChromaDex
$4.37

0.19 (4.55%)

11/27/17
HCWC
11/27/17
NO CHANGE
Target $8
HCWC
Buy
ChromaDex price target raised to $8 from $6 at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju raised his price target for ChromaDex to $8 saying the company reported a "solid" financial position in Q3. To reflect the potential impact of the Watsons distribution arrangement, the analyst raised his 2018 revenue estimate for ChromaDex to $71M from $60M. He keeps a Buy rating on the shares.
09/25/17
LTCO
09/25/17
INITIATION
Target $7
LTCO
Buy
ChromaDex initiated with a Buy at Ladenburg
Ladenburg Thalmann analyst Jeffrey Cohen started ChromaDex with a Buy rating and $7 price target.
09/11/17
HCWC
09/11/17
NO CHANGE
Target $6
HCWC
Buy
ChromaDex price target raised to $6 from $5 at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju raised his price target for ChromaDex to $6 citing the company's partnership with the Hong Kong-based retailer, A.S. Watson. The analyst notes that CK Hutchison, whose Chairman is Li Ka-shing, owns 75% of Watsons. Li Ka-shing has now invested over $25M in ChromaDex, so Watsons should be incentivized to support the Tru Niagen launch, Selvaraju tells investors in a research note. He anticipates the partnership in 2018 could result in up to $10M in Tru Niagen-related revenue. The analyst reiterates a Buy rating on ChromaDex.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.